Contribution of individual cytochrome P450 isozymes to the O-demethylation of the psychotropic β-carboline alkaloids harmaline and harmine

被引:106
作者
Yu, AM
Idle, JR
Krausz, KW
Küpfer, A
Gonzalez, FJ
机构
[1] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA
[2] Univ Bern, Dept Clin Pharmacol, Bern, Switzerland
关键词
D O I
10.1124/jpet.102.047050
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The psychotropic beta-carboline alkaloids, showing high affinity for 5-hydroxytryptamine, dopamine, benzodiazepine, and imidazoline receptors and the stimulation of locus coeruleus neurons, are formed endogenously from tryptophan-derived indolealkylamines through the Pictet-Spengler condensation with aldehydes in both plants and mammals. Cytochromes P450 1A1 (18.5), 1A2 (20), and 2D6 (100) catalyzed the O-demethylation of harmaline, and CYP1A1 (98.5), CYP1A2 (35), CYP2C9 (16), CYP2C19 (30), and CYP2D6 (115) catalyzed that of harmine (relative activities). The dehydrogenation/aromatization of harmaline to harmine was not carried out by aromatase (CYP19), CYP1A2, CYP2C9, CYP2D6, CYP3A4, pooled recombinant cytochromes P450, or human liver microsomes (HLMs). Kinetic parameters were calculated for the O-demethylations mediated by each isozyme and by pooled HLMs. K-cat (min(-1)) and K-m (muM) values for harmaline were: CYP1A1, 10.8 and 11.8; CYP1A2, 12.3 and 13.3; CYP2C9, 5.3 and 175; CYP2C19, 10.3 and 160; and CYP2D6, 39.9 and 1.4. Values for harmine were: CYP1A1, 45.2 and 52.2; CYP1A2, 9.2 and 14.7; CYP2C9, 11.9 and 117; CYP2C19, 21.4 and 121; and CYP2D6, 29.7 and 7.4. Inhibition studies using monoclonal antibodies confirmed that CYP1A2 and CYP2D6 were the major isozymes contributing to both harmaline (20% and 50%, respectively) and harmine (20% and 30%) O-demethylations in pooled HLMs. The turnover numbers for CYP2D6 are among the highest ever reported for a CYP2D6 substrate. Finally, CYP2D6-transgenic mice were found to have increased harmaline and harmine O-demethylase activities as compared with wild-type mice. These findings suggest a role for polymorphic CYP2D6 in the pharmacology and toxicology of harmine and harmaline.
引用
收藏
页码:315 / 322
页数:8
相关论文
共 54 条
[1]   HYPOTHERMIC EFFECT OF HARMALA ALKALOID IN RATS - INVOLVEMENT OF SEROTONERGIC MECHANISM [J].
ABDELFATTAH, AFM ;
MATSUMOTO, K ;
GAMMAZ, HAK ;
WATANABE, H .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1995, 52 (02) :421-426
[2]  
AIRAKSINEN MM, 1981, MED BIOL, V59, P190
[3]   N-methylation ability for azaheterocyclic amines is higher in Parkinson's disease: nicotinamide loading test [J].
Aoyama, K ;
Matsubara, K ;
Okada, K ;
Fukushima, S ;
Shimizu, K ;
Yamaguchi, S ;
Uezono, T ;
Satomi, M ;
Hayase, N ;
Ohta, S ;
Shiono, H ;
Kobayashi, S .
JOURNAL OF NEURAL TRANSMISSION, 2000, 107 (8-9) :985-995
[4]   OCCURRENCE OF 6-HYDROXY-1-METHYL-1,2,3,4-TETRAHYDRO-BETA-CARBOLINE IN TISSUES AND BODY-FLUIDS OF RAT [J].
BECK, O ;
LUNDMAN, A .
BIOCHEMICAL PHARMACOLOGY, 1983, 32 (09) :1507-1510
[5]   Genotoxic and recombinogenic activities of the two β-carboline alkaloids harman and harmine in Saccharomyces cerevisiae [J].
Boeira, JM ;
Viana, AF ;
Picada, JN ;
Henriques, JAP .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2002, 500 (1-2) :39-48
[6]  
BUDAVRI S, 1996, MERCK INDEX ENCY CHE
[7]   SPECIES AND PHENOBARBITONE-INDUCED DIFFERENCES IN KINETIC CONSTANTS OF LIVER MICROSOMAL HARMINE O-DEMETHYLATION [J].
BURKE, MD ;
UPSHALL, DG .
XENOBIOTICA, 1976, 6 (05) :321-328
[8]  
Collins M A, 1987, Adv Neurol, V45, P179
[9]   Alkaloids, alcohol and Parkinson's disease [J].
Collins, MA .
PARKINSONISM & RELATED DISORDERS, 2002, 8 (06) :417-422
[10]   INDOLE-N-METHYLATION OF BETA-CARBOLINES - THE BRAINS BIOACTIVATION ROUTE TO TOXINS IN PARKINSONS-DISEASE [J].
COLLINS, MA ;
NEAFSEY, EJ ;
MATSUBARA, K ;
COBUZZI, R ;
ALBORES, R ;
FIELDS, J ;
ROLLEMA, H .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1992, 648 :263-265